Company: CRL
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001104659-25-030908
Chunk: 38

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 38
---
 Includes 9,734 shares of common stock subject to options held by Ms. Creamer that are exercisable within 60 days of March 21, 2025. (7) Includes 14,847 shares of common stock subject to options held by Ms. Girshick that are exercisable within 60 days March 21, 2025. (8) Includes 12,844 shares of common stock subject to options held by Mr. LaPlume that are exercisable within 60 days of March 21, 2025. (9) Includes 8,825 shares of common stock subject to options held by Dr. Andrews that are exercisable within 60 days of March 21, 2025 and 559 RSUs held by Dr. Andrews that vest within 60 days of March 21, 2025. (10) Includes 8,252 shares of common stock subject to options held by Mr. Bertolini that are exercisable within 60 days of March 21, 2025 and 953 RSUs held by Mr. Bertolini that vest within 60 days of March 21, 2025. (11) Includes 1,710 shares of common stock subject to options held by Ms. Kemps-Polanco that are exercisable within 60 days of March 21, 2025 and 844 RSUs held by Ms. Kemps-Polanco that vest within 60 days of March 21, 2025. (12) Includes 5,713 shares of common stock subject to options held by Dr. Kochevar that are exercisable within 60 days of March 21, 2025 and 559 RSUs held by Dr. Kochevar that vest within 60 days of March 21, 2025. (13) Includes 6,704 shares of common stock subject to options held by Mr. Llado that are exercisable within 60 days of March 21, 2025 and 865 RSUs held by Mr. Llado that vest within 60 days of March 21, 2025. (14) Includes 8,182 shares of common stock subject to options held by Dr. Mackay that are exercisable within 60 days of March 21, 2025 and 931 RSUs held by Dr. Mackay that vest within 60 days of March 21, 2025. (15) Includes 5,713 shares of common stock subject to